SCHEMBL21752958

SCHEMBL21752958

COC(=O)CCc1cc2n(n1)CCNC2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
TSHR P16473 2/20 0.33
MIF P14174 1/20 0.32
ILK Q13418 1/20 0.32
EGFR P00533 2/20 0.31
HRH3 Q9Y5N1 1/20 0.31
KDM4E B2RXH2 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
CYP11B1 P15538 2/20 0.30
CYP11B2 P19099 2/20 0.30
HTR2A P28223 2/20 0.30
HTR2C P28335 2/20 0.30
MAPK1 P28482 1/20 0.30
CHRM3 P20309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31173435 0.88 PDCD1 (0.40) PDCD1CD274TSHRHRH3KDM4E
SCHEMBL31173413 0.86 PDCD1 (0.34) PDCD1CD274ILKKDM4EALDH1A1
SCHEMBL21753825 0.84 PDCD1 (0.39) PDCD1CD274
SCHEMBL30793254 0.75 CHRNB2 (0.32) PDCD1CD274
SCHEMBL31739620 0.75 CXCR4 (0.34) PDCD1CD274
SCHEMBL3548738 0.74 PDCD1 (0.44) PDCD1CD274HTR2AHTR2C
SCHEMBL30793145 0.71 CXCR4 (0.33) PDCD1CD274
SCHEMBL22104649 0.71 PDCD1 (0.41) PDCD1CD274KDM4EALDH1A1HTR2A
SCHEMBL31739519 0.69 CXCR4 (0.33) PDCD1CD274ILK
SCHEMBL31739713 0.69 NPSR1 (0.37) PDCD1CD274KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020040326-A1 PHENYLACETIC ACID DERIVATIVE, AND COMPOSITION FOR PREVENTING OR TREATING AUTOIMMUNE DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT 가천대학교 산학협력단 2020-02-27 WO disclosed